Consumer Perception of Product Risks and Benefits (PDF)

Gerard Emilien is a Clinician whose research interest is focused in Neuropharmacology, Neuropsychiatric diseases and Psychology. A University graduate of Liege University, Belgium, he completed a Diploma in Clinical Neurology from University College London. Gerard is also a fellow of the Royal College of Physicians from UK (Glasgow and Edinburg). He started his clinical research career in the department of Pharmacology at Liege University before he moved to clinical research in Pharma. With his clinical research background in academia (Visiting Professor in Neurology from Louvain University) and Pharmaceutical industry, he has authored several books and scientific papers in the behavioral sciences & Neuropsychiatry in peered review journals. Gerard was also Project Director in Clinical Neuroscience for Pfizer for 16 years where he was responsible for CNS projects and was involved in 3 successful global Marketing Authorization dossiers.

Rolf Weitkunatjoined PMI in 2005, after being a senior lecturer at the School of Public Health and Epidemiology of the Medical Faculty of the University of Munich, Germany, from 1993 on. Habilitation (assistant professor/state doctorate) in biometry and epidemiology in 2001. Previously (1990-1992) working in the biostatistics department of a clinical research organization and as a post doc at the University of Munich. Primary academic training in clinical psychology and neurophysiology, University of Tübingen, Germany (doctorate in psychology in 1987). Currently lecturing epidemiology at the universities of Munich (Germany) and Fribourg (Switzerland). Areas of research include smoking and health, behavioral and social epidemiology, statistical computing, signal processing, meta-analysis methods, and others. Various publications include books on signal processing, statistical computing and methods and concepts of behavioral and social epidemiology, as well as articles in peer-review journals.

Frank Lüdicke joined